Get started Log in

KRON — Kronos Bio Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
$53.65m
Enterprise Value
-$46.08m
Revenue
$9.85m

Brief: Kronos Bio Q1 net loss USD 26.238 million
10/05/2023 21:55
Brief: Kronos Bio Reports Recent Business Progress And First-Quarter 2023 Financial Results
10/05/2023 21:17
Kronos Bio Inc expected to post a loss of 44 cents a share - Earnings Preview
28/04/2023 12:49
Brief: Kronos Bio Appoints Roger Dansey To Board Of Directors
24/04/2023 22:35
Brief: Kronos Bio Announces Changes To Board Of Directors
11/04/2023 21:07
Kronos Bio Inc reports results for the quarter ended in December - Earnings Summary
15/03/2023 21:53
Brief: Kronos Bio Q4 net loss USD 31.8 million
15/03/2023 20:25
Brief: Kronos Bio Reports Recent Business Progress And Q4 And Full-Year 2022 Financial Results
15/03/2023 20:09
Kronos Bio Inc expected to post a loss of 59 cents a share - Earnings Preview
20/02/2023 11:44
Brief: Kronos Bio Inc Marianne De Backer Notified Decision To Resign From Board
26/01/2023 22:24
U.S. STOCKS ON THE MOVE-Goldman Sachs, Natural gas, Chipmakers
09/01/2023 19:06
U.S. STOCKS ON THE MOVE-Abercrombie & Fitch, Lululemon Athletica, Oracle
09/01/2023 17:53
U.S. STOCKS ON THE MOVE-Amazon.com, Paya Holdings, Bed Bath & Beyond
09/01/2023 14:25
Brief: Kronos Bio Inc Enters Into A Collaboration And License Agreement With Genentech Inc
09/01/2023 13:48
Kronos Bio gains on oncology deal with Roche's unit Genentech
09/01/2023 13:19
Brief: Kronos Bio Announces Discovery Collaboration With Genentech
09/01/2023 12:16
Brief: Kronos Bio Announces Selection Of Recommended Phase 2 Dose For Oral CDK9 Inhibitor, KB-0742
07/12/2022 21:10
Kronos Bio Inc reports results for the quarter ended in September - Earnings Summary
09/11/2022 05:25
Brief: Kronos Bio Announces Prioritization Of Clinical Portfolio To Focus On Lanraplenib, KB-0742
08/11/2022 23:17
Brief: Kronos Bio Reports Q3 Net Loss Of $0.57 Per Share
08/11/2022 22:46